In 2024, Sumitomo Pharma conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2024 | 2023 | 2022 | 2021-2019 |
|---|---|---|---|---|
Total Waste Generated | 4,330a | 7,760a | 4,757a | |
Total Waste Recovered | 3,603a | 6,421a | 3,442a | |
Total Hazardous Waste Generated | 2,974a | 6,622a | 3,603a | |
Non-Hazardous Waste Disposed | N/A | N/A | N/A |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2024, Sumitomo Pharma generated a total of 4,330metric tonnes of waste.a
Of this amount, 83.21% of Sumitomo Pharma's total waste generated was recovered through methods such as recycling, reuse, or composting, while 0.25% was disposed of through landfilling, incineration, or combustion.The remaining 16.54% was either treated using unspecified methods or not clearly categorized.a
In 2024, Sumitomo Pharma reported a total waste generation of 4,330 metric tonnes, of which 83.21% was recovered through recycling, reuse, or composting.This high recovery rate suggests that Sumitomo Pharma has implemented strong circular economy practices and actively prioritizes sustainable waste management.a
Since 2022, Sumitomo Pharma's total waste generation decreased by 8.98%, including a further 44.2% drop in 2024, highlighting a consistent and deliberate reduction in waste production over time.a
Over the same period, Sumitomo Pharma's waste recovery rate increased by 15%, while holding steady in 2024, suggesting past gains in recovery performance have stabilized.a
Overall, Sumitomo Pharma’s waste generation and recovery data show a mixed and inconsistent trend. A deeper analysis of the company's activities, industry benchmarks, and operational changes is needed to assess its sustainability performance more precisely.